A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This is a double-blind, placebo-controlled study in adults with a diagnosis of moderate-to-severe chronic plaque psoriasis to test the efficacy and safety of piclidenoson in this patient population.
Epistemonikos ID: 8cc70bbdaf18ebcdd5a298a69b5ea986609720e3
First added on: Nov 01, 2024